1st Quarter - Amendment
340B HEALTH for 340B HEALTH
Firm
Client
Income
—
Expenses
$181,501
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 21, 2008 | $181,501 | Replaced |
| 1st Quarter - Report | Feb 18, 2009 | $181,501 | Replaced |
| 1st Quarter - Amendment (this page) | Feb 19, 2009 | $181,501 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
HR 2606 and S 1376: Extending 340B Drug Pricing to Inpatient Drugs and improving program integrity Preserving current 340B Patient Definition Opposition to new regulations regarding physician administered drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARISA SCHRADER CONWAY New | — |
| ANNA MANGUM | Leg Assistant for Rep. Visclosky and Fascel |
| EDITH MARSHALL | — |
| ROBERT RECKLAUS New | Chief of Staff for Rep. Carolyn McCarthy (NY-4) |
| TED SLAFSKY | Fellow for Sen. Democratic Policy Comm |
| WILLIAM VON OEHSEN | — |
| COURTNEY YOHE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.